Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAM: Acitretin in Alzheimer's Disease
NCT01078168Phase 2Completed
- Start
- Mar 2010
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of acitretin in Alzheimer's disease (AD). Started Mar 2010; status: completed.
02
Drugs
acitretin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01078168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01078168.